Updates in Surgery

, Volume 66, Issue 2, pp 93–100

An update on liver surgery for cholangiocarcinoma

  • Karim Boudjema
  • Giovanni Battista Levi Sandri
  • Eveline Boucher
  • Tanguy Rohou
  • Michel Rayar
  • Laurent Sulpice
Review Article

DOI: 10.1007/s13304-013-0235-y

Cite this article as:
Boudjema, K., Levi Sandri, G.B., Boucher, E. et al. Updates Surg (2014) 66: 93. doi:10.1007/s13304-013-0235-y
  • 262 Downloads

Abstract

Cholangiocarcinoma is a malignant neoplasm that originates from biliary epithelial cells. Complete tumor resection remains the most effective treatment of intra-hepatic or perihilar cholangiocarcinomas (PHCs). The objectives of this are to update and discuss methods that are likely to increase the resectability of cholangiocarcinomas, and to define the limits beyond which the risks of the treatments outweigh their benefits. We analyzed intra-hepatic cholangiocarcinomas and PHCs separately to determine the site of origin and the resectability of the tumor. We discussed the site at which to perform hepatic optimization prior to surgery, and whether liver transplantation might affect cholangiocarcinoma treatment.

Keywords

CholangiocarcinomaIntra-hepatic cholangiocarcinomaPerihilar cholangiocarcinomaLiver surgeryRennes classification

Copyright information

© Springer-Verlag Italia 2013

Authors and Affiliations

  • Karim Boudjema
    • 1
  • Giovanni Battista Levi Sandri
    • 1
  • Eveline Boucher
    • 2
  • Tanguy Rohou
    • 3
  • Michel Rayar
    • 1
  • Laurent Sulpice
    • 1
  1. 1.Service de Chirurgie Hépatobiliaire et Digestive, Centre Hospitalier Universitaire de RennesUniversité de Rennes 1Rennes CedexFrance
  2. 2.Département d’Oncologie MédicaleCentre Eugène-MarquisRennes CedexFrance
  3. 3.Service d’Imagerie Abdominale et Générale, Centre Hospitalier Universitaire de RennesUniversité de Rennes 1Rennes CedexFrance